phase readout
saveNCT05748171: A Study to Learn More About the Study Medicine Called Inotuzumab Ozogamicin (InO) in Children (1 to <18 Years) With First Relapse ALL
RECRUITINGupdated 1mo ago
community read0 votes
Sponsor: Pfizer. Phase: PHASE2. Conditions: ACUTE LYMPHOBLASTIC LEUKEMIA
view source ↗
comments(0)
5-min edit window · permanent after that